Atticus Wealth Management LLC Has $95,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atticus Wealth Management LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 166.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 237 shares of the medical equipment provider’s stock after buying an additional 148 shares during the quarter. Atticus Wealth Management LLC’s holdings in Intuitive Surgical were worth $95,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Norges Bank bought a new stake in Intuitive Surgical in the 4th quarter valued at $1,313,238,000. WCM Investment Management LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at $575,536,000. International Assets Investment Management LLC raised its stake in Intuitive Surgical by 32,360.5% in the 4th quarter. International Assets Investment Management LLC now owns 686,865 shares of the medical equipment provider’s stock valued at $231,721,000 after acquiring an additional 684,749 shares during the period. Alphinity Investment Management Pty Ltd raised its stake in Intuitive Surgical by 113.2% in the 4th quarter. Alphinity Investment Management Pty Ltd now owns 1,276,158 shares of the medical equipment provider’s stock valued at $430,525,000 after acquiring an additional 677,455 shares during the period. Finally, Coatue Management LLC raised its stake in Intuitive Surgical by 65.7% in the 4th quarter. Coatue Management LLC now owns 1,301,595 shares of the medical equipment provider’s stock valued at $439,106,000 after acquiring an additional 516,054 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of several recent research reports. BTIG Research increased their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Robert W. Baird lowered their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Stifel Nicolaus increased their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Jefferies Financial Group increased their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Finally, The Goldman Sachs Group initiated coverage on Intuitive Surgical in a research report on Thursday, May 30th. They issued a “buy” rating and a $500.00 price target on the stock. Five analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $403.67.

Intuitive Surgical Stock Down 0.1 %

ISRG stock traded down $0.26 during midday trading on Friday, hitting $444.85. The company’s stock had a trading volume of 3,106,192 shares, compared to its average volume of 1,372,778. The stock’s 50-day moving average price is $403.83 and its 200 day moving average price is $383.12. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $447.11. The stock has a market cap of $157.79 billion, a price-to-earnings ratio of 80.30, a PEG ratio of 5.75 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the previous year, the firm earned $1.00 earnings per share. The business’s revenue was up 11.5% on a year-over-year basis. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Myriam Curet sold 5,318 shares of the company’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now owns 298 shares of the company’s stock, valued at approximately $110,456.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Myriam Curet sold 5,318 shares of the business’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the sale, the executive vice president now directly owns 298 shares in the company, valued at approximately $110,456.68. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total value of $589,484.00. The disclosure for this sale can be found here. Insiders have sold 17,956 shares of company stock valued at $6,927,011 in the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.